As AMR emerges, new strategies for the treatment of infection and identification of resistant microbes are crucial. The workshop 'Feeding the AMR Therapeutics Pipeline' will bring together academics, industry, innovators, and policymakers to discuss the global antimicrobial development pipeline, identify gaps and opportunities for future research and development, and support collaboration for creative solutions to real-world problems facing therapeutics development in the context of antimicrobial resistance (AMR).
This JPIAMR activity, led by the UK Medical Research Council (MRC) with support from Sweden (SRC), South Africa (SAMRC), Korea (NRF), France (ANR), and Canada (CIHR) is delivered as part of JPIAMR’s mission to enable global coordination of research. The main goals of the workshop are:
To showcase therapeutics research and improve links between academia, industry and policy makers in the context of the wider global antimicrobial therapeutics community
To identify gaps and opportunities in therapeutics research.
Margo Warren will present aspects of the methodology for the Antimicrobial Resistance Benchmark on a panel moderated by Patrick Stewart, Director General of Health Canada. Other panellists include Oliver Williams from the Wellcome Trust, Yann Ferrisse from GARDP, and Mirfin Mpundu from ReAct Africa.
The discussion will follow a keynote presentation from Professor Dame Sally Davies with an introduction from Pierre Sabourin, Assistant Deputy Minister, Health Canada. Panellists are expected to discuss gaps in access to antibiotics in low-and middle-income countries; existing stewardship barriers; the impact of COVID-19 on antimicrobial resistance; and new opportunities to track patterns of resistance and ensure novel medicines and vaccines aimed at fighting drug-resistant infections reach those most in need.
Additional details about the event can be found here.